FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2011/12/002204 [Registered on: 05/12/2011] Trial Registered Retrospectively
Last Modified On: 10/10/2011
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Effect of Vyaghrihareetaki Avaleha and Granules on Tamaka Shwasa (Bronchial Asthma) 
Scientific Title of Study   Pharmaceutical Standardization of Vyaghrihareetaki Avaleha and Granules and their effect on Tamaka Shwasa (Bronchial Asthma) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Roshy Joseph C 
Designation  Ph.D. Scholar 
Affiliation  Institute for Post Graduate Teaching and Research in Ayurveda 
Address  Department of Rasa shastra and Bhaishajya kalpana Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar

Jamnagar
GUJARAT
361008
India 
Phone  9624775660  
Fax    
Email  himaroshy@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Biswajyoti Patgiri 
Designation  Reader 
Affiliation  Institute for Post Graduate Teaching and Research in Ayurveda 
Address  Department of Rasa shastra and Bhaishajya kalpana Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar

Jamnagar
GUJARAT
361008
India 
Phone  9426947438  
Fax    
Email  patgiri06@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Roshy Joseph C 
Designation  Ph.D. Scholar 
Affiliation  Institute for Post Graduate Teaching and Research in Ayurveda 
Address  Department of Rasa shastra and Bhaishajya kalpana Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar

Jamnagar
GUJARAT
361008
India 
Phone  9624775660  
Fax    
Email  himaroshy@gmail.com  
 
Source of Monetary or Material Support  
Institute for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar 361008 
 
Primary Sponsor  
Name  Institute for Post Graduate Teaching and Research in Ayurveda  
Address  Gujarat Ayurved University Jamnagar - 361008 Gujarat 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Roshy Joseph C  Department of Rasa shastra and Bhaishajya kalpana  Institute for Post Graduate Teaching and Research in ayurveda Gujarat Ayurved University jamnagar 361008
Jamnagar
GUJARAT 
9624775660

himaroshy@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Tamaka shwasa Bronchial asthma ,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Vyaghrihareetaki avaleha (Jaggery based)  10 gms twice daily for 4 weeks 
Comparator Agent  Vyaghrihareetaki avaleha (Sugar candy based)  10 gms twice daily for 4 weeks 
Comparator Agent  Vyaghrihareetaki granules  10 gms twice daily for 4 weeks 
 
Inclusion Criteria  
Age From  16.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients having signs and symptoms of Tamaka Shwasa as described in Ayurvedic classics.
2. Mild persistent cases of Asthma (as per WHO GINA Guideline) of duration more than 6 months.
3. Symptoms/exacerbation (Wheeze, cough and breathlessness) more than once a week but less than once a day in frequency
 
 
ExclusionCriteria 
Details  1. Age more than 60 years and below 16 years.
2. Mild intermittent, Moderated persistent, severe persistent to severe Asthma.
3. Dyspnoea resulting from other diseases like left ventricular failure, COPD (Chronic Bronchitis, Emphysema), upper respiratory tract obstruction, bronchiectasis, cases of tuberculosis, interstitial lung disease/occupational lung disease, tropical pulmonary eosinophilia & allergic bronchopulmonary aspergillosis etc.
4. Patients having anaemia, pneumonia, tuberculosis, lung cancer, lung abscess and other such complicated conditions.
5. Patients having diabetes, hypertension, Chronic and Acute renal failure etc. conditions in which urination is markedly diminished or excessive were excluded.
6. HIV positive cases.
7. Pregnant/lactating mother.
8. Patients having classical symptoms of Maha, Urdha, Chinna and Kshudra Shwasa.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.Changes in the cardinal symptoms of Tamaka shwasa.
2. Changes in ACQ and ACT score and PEFR. 
0, 4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Respiratory rate and Breath holding time  0, 4 weeks 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= ""
Final Enrollment numbers achieved (India)="" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   10/07/2010 
Date of Study Completion (India) Date Missing 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  
This study is an Open, Randomized, Controlled, Clinical study to evaluate the efficacy of Group A - Vyaghrihareetaki avaleha (jaggery based), Group B - Vyaghrihareetaki avaleha (sugar candy based), Group C - Vyaghrihareetaki granules (sugar candy based) in the management of Tamaka shwasa (Bronchial asthma). The primary outcome measures are Changes in signs and symptoms of Tamala shwasa, ACQ, ACT score, Respiratory rate, Breath holding time, PEFR changes before treatment and after 4 weeks.   
 
Close